Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Laura C Michaelis
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
506 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- John L Mcclellan Memorial Veterans Hospital
Little Rock, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Fresno Cancer Center
Fresno, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, United States
- Kaiser Permanente-Redwood City
Redwood City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- the Permanente Medical Group-Roseville Radiation Oncology
Roseville, California, United States
- Kaiser Permanente Downtown Commons
Sacramento, California, United States
- Kaiser Permanente Sacramento Medical Center
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- South Sacramento Cancer Center
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Stanford Cancer Center South Bay
San Jose, California, United States
- Kaiser Permanente San Leandro
San Leandro, California, United States
- Kaiser Permanente-San Rafael
San Rafael, California, United States
- Kaiser San Rafael-Gallinas
San Rafael, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Feb 2018
- Primary completion
- 1 Aug 2023
- Completion
- 26 Jun 2024
- Last update posted
- 16 Jan 2025
- Registered enrollment
- 76
- Registry id
- NCT03092674
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.